Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.150
+0.040 (1.90%)
Aug 4, 2026, 1:41 PM EDT - Market open
Lipocine Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.98 | 5.21 | 6.21 | 4.77 | 3.15 | 2.95 |
Short-Term Investments | 18.29 | 9.72 | 15.43 | 17.26 | 29.38 | 41.67 |
Cash & Short-Term Investments | 23.27 | 14.93 | 21.63 | 22.04 | 32.53 | 44.62 |
Cash Growth | 29.72% | -30.98% | -1.82% | -32.26% | -27.09% | 126.86% |
Other Receivables | 0.29 | 1.16 | 0.21 | 0.05 | 0.08 | 0.25 |
Total Trade Receivables | 0.29 | 1.16 | 0.21 | 0.05 | 0.08 | 0.25 |
Other Current Assets | 0.18 | 0.79 | 0.48 | 0.77 | 1.52 | 1.51 |
Total Current Assets | 23.74 | 16.88 | 22.32 | 22.86 | 34.14 | 46.38 |
Net Property, Plant & Equipment | 0.07 | 0.1 | 0.17 | 0.12 | 0.13 | 0.01 |
Long-Term Investments | - | - | - | - | - | 2.02 |
Other Long-Term Assets | 0.02 | 0.02 | 0.02 | 0.02 | 3.28 | 4.07 |
Total Assets | 23.84 | 17.01 | 22.51 | 23 | 37.54 | 52.48 |
Accounts Payable | 0.68 | 0.97 | 0.27 | 1.4 | 0.6 | 1.29 |
Accrued Expenses | 1.07 | 1.24 | 0.92 | 1.22 | 1.08 | 1.02 |
Current Portion of Long-Term Debt | - | - | - | - | - | 2.31 |
Unearned Revenue | 0.32 | 0.32 | 0.32 | - | - | - |
Other Current Liabilities | - | - | - | 0.02 | - | 1 |
Total Current Liabilities | 2.07 | 2.53 | 1.51 | 2.63 | 1.68 | 5.62 |
Other Long-Term Liabilities | - | - | - | - | 0.23 | 1.3 |
Total Long-Term Liabilities | - | - | - | - | 0.23 | 1.3 |
Total Liabilities | 2.07 | 2.53 | 1.51 | 2.63 | 1.91 | 6.91 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Treasury Stock | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
Additional Paid-in Capital | 237.5 | 223.9 | 220.79 | 220.17 | 219.11 | 218.29 |
Accumulated Other Comprehensive Income | -0.01 | 0 | 0.01 | 0.01 | -0.02 | -0.02 |
Retained Earnings | -215.69 | -209.4 | -199.77 | -199.78 | -183.43 | -172.67 |
Shareholders' Equity | 21.77 | 14.48 | 21 | 20.37 | 35.63 | 45.57 |
Total Liabilities & Equity | 23.84 | 17.01 | 22.51 | 23 | 37.54 | 52.48 |
Total Debt | - | 0 | 0 | 0 | 0 | 2.31 |
Net Cash (Debt) | 23.27 | 14.93 | 21.63 | 22.04 | 32.53 | 42.31 |
Net Cash Growth | 29.72% | -30.98% | -1.82% | -32.26% | -23.11% | 200.54% |
Net Cash Per Share | 3.43 | 2.62 | 3.99 | 4.18 | 6.19 | 8.21 |
Book Value | 21.77 | 14.48 | 21 | 20.37 | 35.63 | 45.57 |
Book Value Per Share | 3.21 | 2.54 | 3.87 | 3.87 | 6.78 | 8.84 |
Tangible Book Value | 21.77 | 14.48 | 21 | 20.37 | 35.63 | 45.57 |
Tangible Book Value Per Share | 3.21 | 2.54 | 3.87 | 3.87 | 6.78 | 8.84 |